TNF and irritable bowel syndrome: Antidepressants exert their anti-inflammatory properties by reducing the production of proinflammatory cytokines (IL-1β, IL-10, IL-4 and TNF-a) and downregulating the expression of nuclear factor kB, which are hypothesized to play a key role in IBD pathogenesis [154].